Tenet Healthcare is a medical care facility company located in Texas, United States, which is part of the Healthcare sector, and is traded under the ticker THC on the NYSE exchange.
Tenet Healthcare stock last closed at $91.08, down 5.13% from the previous day, and has increased 37.29% in one year. It has overperformed other stocks in the Medical Care Facilities industry by 0.35 percentage points. Tenet Healthcare stock is currently +78.45% from its 52-week low of $51.04, and -15.51% from its 52-week high of $107.80.
As of Apr 18, 2024, there are 100M THC shares outstanding. The market capitalization of THC is $9.11B. In the past 24 hours, 2.33M THC shares were traded.
You will need an online brokerage account to access the NYSE market and buy THC stock.
Based on our experience, eToro is the best online stock brokerage. eToro gives you:
Get $10 towards your purchase of stock by creating an account with eToro today.
Open eToro AccountNow that you've chosen the right brokerage, you'll need to fill out some personal details so you can invest in THC stock today.
Now that you have filled out your info on the stocks app, your next step is to transfer the money for your investment:
Check out the tutorial below if you need help transferring funds into your new investment account.
After you have figured out the best place to buy Tenet Healthcare stock, it's critical to evaluate their stock before you invest, so you truly understand the risk as well as the opportunity.
WallStreetZen was created to help everyday investors do more accurate fundamental analysis.
You can view all of the due diligence checks on THC's stock page.
You can use many financial metrics, analyses, models, and charts to gauge THC's true value.
Using relative valuations measures:
You can access additional valuation analysis on THC's stock here.
Out of 12 Equities analysts who research THC, the consensus analyst rating on Tenet Healthcare is a Strong Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
Andrew Mok, a bottom 15% analyst from Barclays initiates coverage on THC with a strong buy rating and announces their THC price target of $113.00, on Mar 6, 2024.
David S Macdonald, a top 9% analyst from Truist Securities maintains THC with a strong buy rating and raises their THC price target from $92.00 to $105.00, on Feb 9, 2024.
Truist Securities's David S Macdonald raised their price target on Tenet Healthcare (NYSE: THC) by 14.1% from $92 to $105 on 2024/02/10. The analyst maintained their Strong Buy rating on the stock.
Following the 2024/02/08 release of Tenet Healthcare's Q4 and FY 2023 earnings report, Macdonald pointed to the "strong results and normalized guidance calling for attractive adjusted EBITDA growth" as the catalysts for their price target increase.
The analyst detailed that "Tenet Healthcare's Ambulatory Surgical Center trends remain strong, core hospital volumes are solid, and ongoing investments on several fronts, including labor and high acuity service lines, continue to bear fruit."
Tenet Healthcare reported:
For Q4 2023:
For FY 2023:
Management guided:
For Q1 2024:
For FY 2024:
M.D., Chairman & CEO Saum Sutaria commented: "Our businesses performed exceptionally well in 2023, driven by strong same facility revenue growth and disciplined operating management.
"We carry momentum into 2024 and are focused on continuing to expand access to care and investing in cutting-edge technology for our patients and physician partners, while strategically reducing our debt and growing our ambulatory care and hospital businesses."
Ben Hendrix, a top 18% analyst from RBC Capital maintains THC with a buy rating and raises their THC price target from $97.00 to $109.00, on Feb 9, 2024.
Calvin Sternick, a top 29% analyst from JP Morgan maintains THC with a strong buy rating and lowers their THC price target from $91.00 to $81.00, on Nov 17, 2023.
Brian Tanquilut, a top 21% analyst from Jefferies maintains THC with a strong buy rating and lowers their THC price target from $95.00 to $85.00, on Nov 14, 2023.
You can dig deeper into what analysts are saying on the Tenet Healthcare stock forecast page.
Last year, THC earnings were $611.00M. In the last five year, THC's earnings have gone up by 42.58% per year. This was faster than the Medical Care Facilities industry average of 11.7%.
Last year, THC revenue was $20.56B. During the past 5 year, THC's revenue has increased by 2.35% per year. This was slower than the Medical Care Facilities industry average of 7.69%.
Dig into THC's earnings and revenue performance here.
In the past year, insiders at THC have sold more shares than they have bought.
Richard J. Mark, Director of THC, was the latest THC insider to sell. They sold $1,385,720.00 worth of THC shares on Mar 12, 2024.
Dig into more about who owns THC shares here.
No, Tenet Healthcare doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
There are two primary options:
Hit the Open Trade button and eToro will place the order.
If you need more assistance investing in stocks on eToro, watch the how to video below:
Now that you own some THC shares, you'll want to keep up with your investment.
Add THC to a watchlist to get notified of the latest news about your THC stock.
To summarize, here are the 6 steps to buy Tenet Healthcare stock:
If you need a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you want to keep tabs on your investment in Tenet Healthcare, create a watchlist on WallStreetZen today.